Spis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY

POLISH FINANCIAL SUPERVISION AUTHORITY

UNI - EN REPORT No 51 / 2023
Date of issue: 2023-12-27
Short name of the issuer
KRKA
Subject
Notification of transactions by persons discharging managerial responsibilities
Official market - legal basis
art. 19. 3 MAR.
Unofficial market - legal basis
Contents of the report:
Based on the provisions of the Rules of the Ljubljana Stock Exchange and Article 19 of Regulation (EU) No 596/2014, Krka, d. d., Novo mesto announces:

The Member of the Supervisory Board of Krka, d. d., Novo mesto, Matej Lahovnik, informed the company that on 22 December 2023 he acquired 400 shares of the company with the symbol KRKG (ISIN: SI0031102120) for his own account on the official market of the Ljubljana Stock Exchange at a weighted average price of EUR 109.50.

The transactions are not linked to the exercise of a share option programme.


The notice will be published on the company's website (www.krka.biz) from 22 December 2023 onwards, for a period of at least 5 years.
Annexes
File Description

KRKA, TOVARNA ZDRAVIL D.D.
(fullname of the issuer)
KRKA Farmaceutyczny (far)
(short name of the issuer) (sector according to clasification
of the WSE in Warsow)
8501 Nove Mesto
(post code) (city)
Smarjeska 6
(street) (number)
+386 7 331 21 11 +386 7 332 15 37
(phone number) (fax)
(e-mail) (web site)
nie dotyczy
(NIP) (REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Date Name Position / Function Signature
2023-12-27 Jože Colarič President of the Management Board and CEO